Innovative sweat sampling techniques could revolutionize diagnostics, offering insights into glucose levels and environmental ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

The M-Strip developed by IOTA Diagnostic uses period blood to screen for high-risk HPV, the main cause of cervical cancer.

As of Tuesday, December 09, Teleflex Incorporated’s TFX share price has surged by 9.03%, which has investors questioning if this is right time to sell.

Women and couples are facing a lack of choice when it comes to local sperm donors in Australia, leading to waitlists and an increasing reliance on men from overseas. So, should we start paying guys to ...

The global medical specialty bag market, valued at USD 3.8 billion in 2025, is set for a decade of accelerated expansion, projected to reach USD 8.9 billion by 2035. This strong 8.9% CAGR reflects the ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

New evidence from a six-country study led by the Montreal Children's Hospital and Children's National Hospital shows simple ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.